BiotechTube
Home/BenevolentAI/Joanna Shields, OBE
JS

Joanna Shields, OBE

Chief Executive Officer

BenevolentAI

Therapeutic Areas

ImmunologyNeurologyInflammatory Diseases

BenevolentAI Pipeline

DrugIndicationPhase
BEN-2293 / AZD3470Atopic DermatitisPhase 2a
BEN-8744Ulcerative ColitisPhase 1b
Internal ProgramAmyotrophic Lateral Sclerosis (ALS)Preclinical

Leadership Team at BenevolentAI

DA
Dr. Anne Phelan
Chief Scientific Officer
DM
Dr. Michael Branney
Chief Technology Officer
B(
Baroness (Lola) Young of Hornsey, OBE
Independent Non-Executive Director
View full BenevolentAI profile